Regeneron Pharmaceuticals
$68.35 B
Share price
Change (1 day)
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: $68.35 Billion

As of August 2022 Regeneron Pharmaceuticals has a market cap of $68.35 Billion. This makes Regeneron Pharmaceuticals the world's 205th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$68.35 B0.65%
2021$67.91 B31.74%
2020$51.55 B24.5%
2019$41.40 B1.7%
2018$40.71 B0.79%
2017$40.39 B4.33%
2016$38.71 B-31.85%
2015$56.81 B35.19%
2014$42.02 B53.15%
2013$27.43 B64.85%
2012$16.64 B224.35%
2011$5.13 B74.8%
2010$2.93 B49.69%
2009$1.96 B34.11%
2008$1.46 B-23.21%
2007$1.90 B45.08%
2006$1.31 B46.27%
2005$0.89 B74.43%
2004$0.51 B-37.05%
2003$0.81 B-0.78%
2002$0.82 B-33.46%
2001$1.23 B

End of Day market cap according to different sources

On Aug 9th, 2022 the market cap of Regeneron Pharmaceuticals was reported to be:

$67.81 Billion
by Yahoo Finance
$67.81 Billion
by CompaniesMarketCap
$68.34 Billion
by Nasdaq
$66.72 Billion
by Iex Cloud
$68.74 Billion
by Reuters

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$447.69 B 554.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$190.40 B 178.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$133.11 B 94.74%๐Ÿ‡บ๐Ÿ‡ธ USA
$112.17 B 64.10%๐Ÿ‡ซ๐Ÿ‡ท France
$31.69 B-53.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$27.58 B-59.65%๐Ÿ‡บ๐Ÿ‡ธ USA